MED — Medifast Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapNeutral

Annual balance sheet for Medifast, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	110	87.7	150	162	167
Net Total Receivables	0.945	0	8.73	0	—
Total Inventory
Prepaid Expenses
Total Current Assets	307	223	224	214	202
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	80.6	75.6	67.1	48.7	38.5
Other Long Term Assets
Total Assets	398	316	310	284	248
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	170	141	92.3	64.2	43
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	196	161	108	74.1	49.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	202	155	201	210	199
Total Liabilities & Shareholders' Equity	398	316	310	284	248
Total Common Shares Outstanding